Title : The CB1 Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric Tolerability.

Pub. Date : 2016 Dec

PMID : 27493155






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The CB1 Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric Tolerability. Nicotine cannabinoid receptor 1 Rattus norvegicus
2 Here we evaluated the effects of the CB1 neutral antagonist AM4113 on the abuse-related effects of nicotine and its effects on anxiety and depressive-like behavior in rats. Nicotine cannabinoid receptor 1 Rattus norvegicus